Multiple Myeloma An Overview

Multiple myeloma is a malignant disorder characterized by the proliferation of plasma cells. Much insight has been gained into the molecular pathways that lead to myeloma and indeed much more remains to be done. The understanding of these pathways is closely linked to their therapeutic implications...

Full description

Saved in:
Bibliographic Details
Other Authors: Gupta, Ajay (Editor)
Format: Electronic Book Chapter
Language:English
Published: IntechOpen 2012
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_65449
005 20210420
003 oapen
006 m o d
007 cr|mn|---annan
008 20210420s2012 xx |||||o ||| 0|eng d
020 |a 1240 
020 |a 9789533077680 
020 |a 9789535166368 
040 |a oapen  |c oapen 
024 7 |a 10.5772/1240  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a MJCL  |2 bicssc 
100 1 |a Gupta, Ajay  |4 edt 
700 1 |a Gupta, Ajay  |4 oth 
245 1 0 |a Multiple Myeloma  |b An Overview 
260 |b IntechOpen  |c 2012 
300 |a 1 electronic resource (286 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Multiple myeloma is a malignant disorder characterized by the proliferation of plasma cells. Much insight has been gained into the molecular pathways that lead to myeloma and indeed much more remains to be done. The understanding of these pathways is closely linked to their therapeutic implications and is stressed upon in the initial chapters. Recently, the introduction of newer agents such as bortezomib, lenalidomide, thalidomide, liposomal doxorubicin, etc. has led to a flurry of trials aimed at testing various combinations in order to improve survival. Higher response rates observed with these agents have led to their integration into induction therapies. The role of various new therapies vis a vis transplantation has also been examined. Recent advances in the management of plasmacytomas , renal dysfunction, dentistry as well as mobilization of stem cells in the context of myeloma have also found exclusive mention. Since brevity is the soul of wit our attempt has been to present before the reader a comprehensive yet brief text on this important subject. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/3.0/  |2 cc  |4 https://creativecommons.org/licenses/by/3.0/ 
546 |a English 
650 7 |a Oncology  |2 bicssc 
653 |a Oncology 
856 4 0 |a www.oapen.org  |u https://mts.intechopen.com/storage/books/732/authors_book/authors_book.pdf  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/65449  |7 0  |z DOAB: description of the publication